Home >

Xiang Xue Pharmaceutical: Demolition, Demolition, "Lost" 90 Million Yuan Equipment &Nbsp; Mysterious Business Secret Trading.

2011/1/28 10:15:00 60

??? 日本語 Fran?ais English 中文

In December 15th, Guangdong Xiang Xue Pharmaceutical (300147, stock bar) Co., Ltd. (hereinafter referred to as "Xiang Xue pharmaceutical", 300147.SZ) officially entered the gem.

After the listing, the company's market value was more than 5 billion yuan, and was sought after by some institutional investors.

However, the entrepreneur read through the prospectus only to find that the Huazhou pharmaceutical factory of Xiang Xue pharmaceutical factory and its relationship are blurred, not only using the brand of Xiang Xue pharmaceutical company, but also suspected of being invested by Xiang Xue pharmaceutical, and such information has not been disclosed in the prospectus, and it is suspected that it is not related to the related pactions.

Demolition, "lost" 90 million yuan equipment

In the second half of 2008, Xiang Xue pharmaceutical began to be demolished because of the demolition of the factory area.

According to the prospectus, Xiang Xue pharmaceutical received compensation for demolition, amounting to 178 million 58 thousand and 300 yuan.

The compensation for demolition of 178 million 58 thousand and 300 yuan is to compensate for the loss of all the buildings in the factory area of No. 33 of Luo long highway.

According to the prospectus, the demolition losses of Xiang Xue pharmaceutical include:

1. The land use right of the old factory is 9 million 786 thousand and 600 yuan.

2. The net assets that cannot be relocated are 151 million 492 thousand and 900 yuan.

3. The additional cost of the relocation and shutdown of the old factory is 5 million 833 thousand and 400 yuan.

The total amount is 167 million 112 thousand and 900 yuan.

Except for the right to the use of land, the net loss of the net assets that can not be removed is 15149.29 yuan. The details are as follows:

Net value of serial number item

1 housing and buildings 7614.82 6069.36

2 machine equipment 12154.60 9026.34

3 pport 87.38 4.37

4 other 569.44 49.22

Total 20426.24 15149.29

Among them, the original value of the equipment was 121 million 546 thousand yuan, the net value was 90 million 263 thousand and 400 yuan, and the comprehensive new rate reached 74.56%.

"The reason for the higher rate of innovation is

company

In 2004 and 2005, the original plant began to carry out GMP facilities pformation. The equipment and auxiliary facilities of the workshop for extraction and preparation were updated.

Because the new equipment can be used for about 10 years, and the cumulative lifetime is only about 3 years before the relocation. It can be used for a longer period of time, so the new rate of disposal is higher.

But when the company moved, it did not hesitate to dismantle these 7 of the new equipment.

But in the prospectus, there is no place to mention how to dispose of the equipment after being scrapped, is it selling waste products, and if it is sold, how much money will it receive? If there are no waste products, where will the equipment be removed?

The equipment with a net value of 90 million 263 thousand and 400 yuan is evaporated without air and has to be confused.

Is commissioned processing a related paction?

The demolition and demolition of "lost" equipment, Xiang Xue pharmaceutical will be part of the important production processes such as Chinese medicine extraction to other manufacturers, such as Guangdong Huazhou Chinese Medicine Pharmaceutical Co., Ltd., Guigang City GuanFeng Pharmaceutical Co., Ltd., Guangdong Bao Dan Pharmaceutical Co., Ltd., Guangzhou star Pharmaceutical Co., Ltd.

Under the background of commissioned processing, the gross profit margin of the consolidated statement level of Xiang Xue pharmaceutical company was 51.30% and 52.51% respectively in the whole year of 2009 and the first half of 2010.

Regretfully, the entrepreneur found that the first big processing company of Xiang Xue was the multiple mysterious relationship between Huazhou Chinese medicine factory and Xiang Xue pharmaceutical company.

Huazhou Chinese medicine factory is affiliated to Qingping group and Qingping group is also a famous pharmaceutical company.

Huazhou traditional Chinese medicine factory has a main hit.

product

"Citrus grandis" has a long history and reputation. It has always used the trademark and design of "orange mountain".

But later this product gave up the "orange mountain" trademark and changed it to the "Xiang Xue" trademark of Xiang Xue pharmaceutical. Xiang Xue pharmaceutical said it was authorized to use, but also charged royalties.

Why do we give up valuable old brands and spend money on brands that are not related to others? This is a curious thing.

Huazhou Chinese medicine factory has commissioned the processing of Xiang Xue pharmaceutical, and used the trademark of Xiang Xue, their relationship is not ordinary.

In fact, the relationship between Xiang Xue pharmaceutical and suppliers has always been complicated, for example,

Jian an Tang

Not only procurement, but also financing of negotiable instruments.

In fact, the relationship between Huazhou Chinese medicine factory and Xiang Xue pharmaceutical is far from being so simple.

Quote some old news that can be searched.

Please look at the news of China's orange online.

"In January 2008, Guangzhou Xiang Xue pharmaceutical Limited by Share Ltd and Qingping group reached a cooperation in the operation of Huazhou Pharmaceutical Factory Limited, which was invested by Xiang Xue pharmaceutical Limited by Share Ltd and operated in Guangdong Huazhou Chinese medicine factory.

Since the cooperative operation, the company's production and operation has developed greatly.

This year, the company achieved sales of 55 million yuan, and realized 10 million 900 thousand yuan of tax revenue. At present, the production and sales of products are booming and demand exceeds supply.

The company aims to become the largest pharmaceutical production base in western Guangdong in 3 years and enter the top 20 pharmaceutical production enterprises in Guangdong within 5 years.

What is cooperative business? What is capital injection?

Look at the food and Drug Administration of Maoming, Guangdong.

"In August 11th, Huazhou mayor Huang Congnan, vice mayor He Zhenfeng and municipal office director Mo Guanhong and others were inspected under the supervision of Huazhou food and drug administration under the leadership of the Huazhou Bureau.

Mayor Huang visited Huazhou Ji Jun Pharmaceutical Co., Ltd., Huazhou Minsheng Pharmaceutical Co., Ltd., Huazhou ginseng and citrus pharmacy and Huazhou Chinese medicine factory.

Mayor Huang from South China understood the operation of the enterprises in detail, and discussed the development direction of the pharmaceutical enterprises in our city, and put forward the requirements for the development of the enterprises.

In the Chinese herbal medicine factory in Huazhou, Huang mayor learned that since last year, when the company was developing rapidly, it was very happy that the company was developing rapidly, and asked enterprises to seize the unique brand of "tangerine red", deepen the research of the "orange red", introduce science and technology into enterprises, and expand the citrus industry with science and technology.

May I ask, what is stock management?

Why is there no disclosure of Xiang Xue pharmaceutical prospectus, but there is no correlation? Is it the product of potential related pactions?

Xiang Xue pharmaceutical does not say clearly, how can investors dispel doubts?

Lenovo's huge pharmaceutical equipment's silent treatment, whether the company has processed the equipment outside the account and put the cash into the Chinese medicine factory in Huazhou, is really something that needs to be clearly stated in time.